FMC Corporation reports news on its global agricultural sciences business, including crop protection solutions, biologicals, crop nutrition, digital and precision agriculture, and research into herbicide, insecticide and fungicide active ingredients. Company updates commonly cover quarterly results, outlook commentary, dividend declarations, executive conference appearances, and regulatory approvals for products such as Isoflex® active.
FMC news also reflects the operating issues of a crop protection supplier, including regional revenue trends, product commercialization, operational priorities, capital-structure matters, and governance developments affecting its board and incentive plans.
FMC (NYSE: FMC) reported third-quarter 2026 revenue of $106 million as commercial actions weighed on results and it lowered fourth-quarter guidance. Revenue fell 80% year over year, including approximately $639 million of negative commercial-action impacts. Excluding India and those actions, revenue fell 22% to $745 million. GAAP net loss widened to $2.07 billion, reflecting non-cash tax and intangible-asset adjustments alongside the commercial actions. Adjusted EBITDA, a non-GAAP earnings measure, was negative $559 million.
Operating cash flow improved to $7 million. FMC expects fourth-quarter revenue excluding India of $1.04 billion to $1.14 billion and adjusted EBITDA of $210 million to $230 million, down 22% at the midpoint year over year. Full-year free cash flow is now expected at negative $350 million to negative $150 million. Implementation of the commercial actions remains ongoing.
FMC (NYSE: FMC) updated third-quarter 2026 expectations to reflect commercial actions aimed at moving products through distributors and supporting replenishment demand. Revenue is now expected at $65 million to $125 million, with adjusted EBITDA, an adjusted earnings measure before interest, taxes, depreciation and amortization, of negative $565 million to negative $510 million. Estimates include approximately $625 million to $675 million in charges affecting revenue and adjusted EBITDA.
FMC is lowering prices on select products held by customers in Brazil, Argentina, the United States and Canada. It also plans to narrow the gap between U.S. gross and net pricing under its high-rebate model. FMC attributed weaker-than-expected demand partly to higher-priced channel inventory. The company expects covenant compliance at September 30, 2026, but plans bank discussions about potential further covenant changes over the next year.
FMC (FMC) submitted a regulatory dossier for its dual-mode herbicide rimisoxafen to Brazilian authorities for review. This is rimisoxafen's second global submission, following a July 2026 filing with the U.S. Environmental Protection Agency. It is the third novel herbicide active ingredient FMC has submitted for review in Brazil. Classified in herbicide Groups 12 and 32, rimisoxafen showed activity in FMC field testing against small-seeded broadleaf weeds, including resistant Amaranthus palmeri and Amaranthus hybridus.
FMC expects formulated-product submissions to follow as review advances. Rimisoxafen is not registered for sale or use in Brazil or any other country; timing and outcomes remain subject to regulatory review and approval.
FMC (FMC) and Tessenderlo Group announced the closing of an approximately $403 million minority equity investment on September 23, 2026. Tessenderlo Group purchased 30,319,166 shares of FMC common stock at $13.30 per share and now owns approximately 20.0% of FMC's outstanding common stock.
The companies entered into a definitive agreement on June 30, 2026, and satisfied all required closing conditions and regulatory approvals. Tessenderlo Group has the right to nominate one independent director to FMC's board and has nominated its chief executive officer, Luc Tack. Tessenderlo Group is subject to a three-year lock-up and agreed to standstill restrictions for as long as it owns FMC shares.
FMC Corporation (FMC) will release its third quarter 2026 earnings on Thursday, October 29, 2026, after the stock market close via PR Newswire and its investor website.
The company will host a public webcast conference call on Friday, October 30, 2026, at 9:00 a.m. ET. The event will be accessible via internet broadcast at the FMC investor relations site and by telephone for both U.S. and global participants.
FMC (FMC) and biotechnology firm AgroSpheres are advancing two proprietary RNA-based bioinsecticide candidates from discovery into global field trial development across the United States, Brazil and Asia. The biomolecules are designed to target some of the most persistent and economically damaging lepidopteran pests, including fall armyworm and diamondback moth, which together with a few other species drive nearly $14 billion in annual global crop losses and control costs.
The field trials follow several years of laboratory, greenhouse and small-scale field-plot testing, during which the candidates were benchmarked against industry-standard chemistries and, before being advanced, consistently met or exceeded that performance. The products are built on AgroSpheres’ biomodality and AgriCell encapsulation platforms, which use fermentation-based manufacturing and controlled-release delivery to protect biomolecules from UV exposure, heat and moisture while aiming for precise, pest-specific activity and reduced impact on beneficial insects.
FMC (NYSE: FMC) announced that chairman, chief executive officer and president Pierre Brondeau, and executive vice president and chief financial officer Andrew Sandifer, will present at the 2026 Jefferies Global Industrials Conference on September 10, 2026 at 11:30 a.m. Eastern Time.
A live webcast of FMC’s presentation will be available through the company’s investor website at www.fmc.com/investors.
Sabanto, a provider of autonomous tractor retrofit technology, appointed John M. Raines to its Board of Directors, following the close of an oversubscribed Series B funding round led by Leaps by Bayer with multiple agriculture-focused investors participating.
According to Sabanto, the new capital will be used to expand manufacturing and deployment, grow engineering and commercial teams, and invest further in its Vehicle Operating System (vOS) and Vehicle Mission Control (vMC) software. Raines brings more than 30 years of agriculture and technology leadership, including roles at TELUS Digital Agriculture & Consumer Goods, The Climate Corporation and Monsanto, and currently serves on the boards of FMC (NYSE: FMC), Sydenstricker Nobbe Partners, TPNB Bank/Paris Bancshares, and the University of Missouri Board of Curators.
FMC (NYSE:FMC) reported Q2 2026 revenue of $867 million, down 17% year over year; revenue excluding India was $841 million, down 20%. Organic revenue declined 22%. The company posted a GAAP net loss of $187 million (–$1.49 per share) and Adjusted EBITDA of $153 million, down 26%, with adjusted EPS of $0.26, down 62%.
GAAP cash from operations rose to $363 million and free cash flow to $357 million, helped by a $200 million rimisoxafen licensing upfront. FMC outlined about $1 billion of planned proceeds for debt reduction and lowered 2026 guidance: revenue to $3.50–$3.70 billion, Adjusted EBITDA to $620–$680 million, and adjusted EPS to $1.19–$1.49. The board concluded its strategic review and the company expects year-over-year growth to resume in Q4 2026.
FMC (NYSE: FMC) announced that its board of directors has declared a regular quarterly dividend of $0.08 per share. The dividend is payable on October 15, 2026 to shareholders of record at the close of business on September 30, 2026.